<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The rise in bariatric surgery has driven an increased number of complications from venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> (VTE) </plain></SENT>
<SENT sid="1" pm="."><plain>Evidence supports <z:hpo ids='HP_0001513'>obesity</z:hpo> as an independent risk factor for VTE, but the specific derangements underlying the <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> of <z:hpo ids='HP_0001513'>obesity</z:hpo> are not well defined </plain></SENT>
<SENT sid="2" pm="."><plain>To better characterize VTE risk for the purpose of tailoring prophylactic strategies, we developed a protocol for <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> screening in patients presenting for bariatric surgery at our institution </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Between April 2004 and April 2006, 180 bariatric surgery candidates underwent serologic screening for inherited <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> (<z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">Factor V-Leiden mutation</z:e>, low Protein C activity, low Protein S activity, Free <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">Protein S deficiency</z:e>) and acquired <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> (D-Dimer elevation, Fibrinogen elevation, elevation of coagulation factors VIII, IX, and XI, elevation of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> level, and <z:hpo ids='HP_0001976'>Antithrombin III deficiency</z:hpo>) </plain></SENT>
<SENT sid="4" pm="."><plain>Prevalence rate of each <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> in the subject group was compared to the actual prevalence rate of the general population </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Most plasma markers of both inherited and acquired <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> were identified in higher than expected proportions, including D-Dimer elevation in 31%, Fibrinogen elevation in 40%, Factor VIII elevation in 50%, Factor IX elevation in 64%, Factor XI elevation in 50%, and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> in 13% </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0001513'>Obesity</z:hpo> is a well-described demographic risk factor for VTE </plain></SENT>
<SENT sid="7" pm="."><plain>In bariatric surgery candidates routinely screened for serologic markers, both inherited and acquired <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> occurred more frequently than in the general population, and may therefore prove to be useful for individualized VTE risk assessment and prophylaxis </plain></SENT>
</text></document>